Explore Global Companies & Account Intelligence

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

AIB is one of the first licensed Insurance Brokers in Qatar, providing the following services: 1- An insurance broker: 2- Offering the Technical Services and risks studies. 3- Reinsurance Brokerage. 4- Lose Adjusters Where the company offers consulting and insurance solutions and help customers choosing the insurance coverage commensurate with their needs

Alnova startades som familjeföretag för över 30 år sedan och har utvecklats till en av de ledande leverantörerna av balkongsystem i Sverige. Företaget är en etablerad samarbetspartner för såväl bostadsrättsföreningar som stora och små företag. Idag finns många kunder bland de större byggföretagen. Alnova har drygt 30 anställda med kontor, tillverkning och utställning i Göteborg. Alnovas ledord är att leverera kvalitativa, kostnadseffektiva, kundanpassade och kompletta balkongsystem.

Alnutri agora é DGH Foods! Siga-nos: https://www.linkedin.com/company/dghfoods Fundada em 2018, A DGH nasceu para ser uma plataforma de marcas no segmento de mercearia seca, integrando empresas regionais fortes e com grande presença, construindo uma base operacional geográfica de amplo alcance para a distribuição nacional. Tudo isso sem perder a essência e a tradição ligadas às origens de cada uma, mas unificando-as em torno de uma plataforma única de posicionamento e execução. Acreditamos na comida de verdade, em alimentos de baixo processamento e alta qualidade nutricional, selecionando criteriosamente os nossos fornecedores para levar o que há de melhor da natureza para a mesa do consumidor. Trabalhamos continuamente em nossos Centros de Desenvolvimento, para melhorar continuamente o perfil nutricional de nossos produtos, oferecendo novidades cada vez mais relevantes e alinhadas às tendências de alimentação. O nosso portfólio inclui: - Produtos diretos da natureza grãos, especiarias, temperos e chás - Produtos convenientes – com baixo processamento, para tornar a atividade de cozinhar mais fácil – milho de pipoca para micro-ondas, farofas prontas etc. - Complementos. Atualmente, estamos presentes principalmente nas regiões de Minas Gerais, São Paulo, Rio de Janeiro e Espírito Santo, atuando sobretudo nos seguintes canais de distribuição: Varejo alimentar (através das marcas Pink e Hikari); Canais institucionais (foodservice – refeições corporativas, sorveterias e panificadores, através das marcas Supralac e Apetite); Indústrias (ingredientes e aromas para indústrias de alimentos e bebidas); Órgãos públicos (principalmente merendas escolares). Estamos sempre em busca pelos mais selecionados produtores do Brasil e do mundo, para levar aos nossos clientes e consumidores os melhores produtos possíveis.

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-24), Fast Company (Best Workplaces for Innovators 2020-24) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-24), Fast Company (Best Workplaces for Innovators 2020-24) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-24), Fast Company (Best Workplaces for Innovators 2020-24) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

SILENCE DISEASE. AMPLIFY LIFE.™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-24), Fast Company (Best Workplaces for Innovators 2020-24) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

ALO diamonds, česká klenotnická společnost od roku 1995, vyrábí oslnivé šperky s diamanty a barevnými drahokamy různých kolekcí a stylů v jednom z největších kreativních ateliérů ve střední Evropě. V kolekcích ALO diamonds najdete zásnubní, snubní prsteny, řetízky, náušnice a dětské náušnice, přívěsky, náhrdelníky, náramky, brože, manžetové knoflíčky a další šperky v různých cenových relacích. Nákup luxusního šperku je jedním z nejkrásnějších, a také nejdůležitějších momentů vašeho života. Proto je důležité, abyste se při jeho výběru obrátili na skutečné profesionály a požadovali to nejlepší, pokud jde o materiály i zpracování. Šperky značky ALO diamonds vám nabízejí záruku špičkové kvality a trvalé hodnoty, která s časem ještě vzrůstá. Váš luxusní šperk si zaslouží také luxusní ošetření. Proto vám nabízíme celoživotní servis u nás zakoupených šperků, jejich odbornou kontrolu a vyčištění. Samozřejmostí je také profesionální poradenství našich speciálně školených prodejců. Since 1995, the reputable Czech jewellery company has been manufacturing jewels in one of the largest studios in Central Europe. In ALO diamonds collections one can find engagement and wedding rings, chains, earrings and children’s earrings, pendants, bracelets, brooches, cuff buttons, and other jewels at various price levels. Purchasing a luxurious jewel is one of the most beautiful as well as most important moments in our lives. Due to this, it is important to contact real professionals, when choosing one, and to require the best materials and processing. Jewels of the ALO diamonds brand guarantee top quality and sustainable value increasing with the age. Your luxurious jewel deserves luxurious treatment. That is why we offer lifelong servicing of jewels purchased at our place, their professional inspections and cleaning. Professional advisory at our specially trained professional sales managers is granted too.

Founded in 2007 in Curitiba, Brazil, Alo Ingressos has 13 years of experience in the entertainment market and is present throughout Brazil. The company is a reference in end-to-end event management, having pioneered mobile ticket verification. Aside from ticketing, the platform allows management of Access Control, F&B sales (food and beverage), Parking and P2P (direct sales service) sales made by promoters and influencers authorised. The whole operation is managed via a unique control panel. Alo Ingressos technology is available for large, medium and small producers, from a wide variety of segments, as well as independent artists, helping with 360º management of their events. We have already supported the management of over 20 thousand events, have sold over 27 million tickets to over 14 million users in Brazil. We will soon be starting operations in Europe. (We're hiring!)